Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review

BACKGROUND: Quantification of circulating tumor DNA (ctDNA) levels is a reliable prognostic tool in several malignancies. Dynamic changes in ctDNA levels in response to treatment may also provide prognostic information. Here, we explore the value of changes in ctDNA levels in response to immune chec...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Showbaki, Laith, Wilson, Brooke, Tamimi, Faris, Molto, Consolacion, Mittal, Abhenil, Cescon, David W, Amir, Eitan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933752/
https://www.ncbi.nlm.nih.gov/pubmed/36792122
http://dx.doi.org/10.1136/jitc-2022-005854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933752/
https://www.ncbi.nlm.nih.gov/pubmed/36792122
http://dx.doi.org/10.1136/jitc-2022-005854

Ejemplares similares